1985
DOI: 10.1016/s0034-5288(18)31779-x
|View full text |Cite
|
Sign up to set email alerts
|

Trichostrongylus colubriformis: in vitro culture of parasitic stages and their use for the evaluation of anthelmintics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

1986
1986
2018
2018

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 7 publications
0
11
0
Order By: Relevance
“…The medium was based on that developed previously for the culture of Nippostrongylus brasiliensis (Jenkins et al 1980;Jenkins & Carrington, 1982) and used also for the culture of Nematospiroides dubius and T. colubriformis (Rapson et al 1985).…”
Section: Culture Mediummentioning
confidence: 99%
See 3 more Smart Citations
“…The medium was based on that developed previously for the culture of Nippostrongylus brasiliensis (Jenkins et al 1980;Jenkins & Carrington, 1982) and used also for the culture of Nematospiroides dubius and T. colubriformis (Rapson et al 1985).…”
Section: Culture Mediummentioning
confidence: 99%
“…All compounds were tested at least in duplicate at every concentration used. All drugs were evaluated at concentrations ranging by serial double dilution from a concentration at least 4 times greater than that known to inhibit the final moult of T. colubriformis in vitro (Rapson et al 1985), to one for which no inhibitory effects on the aggregation responses of the young adult worms was seen. The lowest dilution at which no worm aggregation was seen was regarded as the minimum inhibitory concentration (m.i.c.)…”
Section: Operation and Interpretation Of The Screenmentioning
confidence: 99%
See 2 more Smart Citations
“…The ability to maintain gastro-intestinal helminths in vitro would enhance the experimental tractability of nematode parasites by facilitating the application of a range of molecular and biochemical tools and analyses in clinically relevant species. Such an advance would prompt a paradigm shift in parasitology research permitting progress in key areas including evaluation of anthelmintics and natural products with anthelmintic properties (Rapson et al ., 1985; Brownlee et al ., 1997; O'Grady and Kotze, 2004; Jansen et al ., 2013), application of transcriptomics to investigate the genetic mechanisms driving anthelmintic resistance (Jansen et al ., 2013), induction of RNAi interference for the identification of novel drug targets (McCoy et al ., 2015), analysis of excretory and secretory products (Young et al ., 1995; Geldhof et al ., 2000; Islam et al ., 2004; Cribb et al ., 2006; Burk et al ., 2014; Thomas et al ., 2016) and interrogation of host–parasite interactions (Kotze and McClure, 2001).…”
Section: Introductionmentioning
confidence: 99%